| Literature DB >> 31261621 |
Mikhail Inyushin1, Daria Meshalkina2, Lidia Zueva3, Astrid Zayas-Santiago3.
Abstract
In vivo tissue transparency in the visible light spectrum is beneficial for many research applications that use optical methods, whether it involves in vivo optical imaging of cells or their activity, or optical intervention to affect cells or their activity deep inside tissues, such as brain tissue. The classical view is that a tissue is transparent if it neither absorbs nor scatters light, and thus absorption and scattering are the key elements to be controlled to reach the necessary transparency. This review focuses on the latest genetic and chemical approaches for the decoloration of tissue pigments to reduce visible light absorption and the methods to reduce scattering in live tissues. We also discuss the possible molecules involved in transparency.Entities:
Keywords: deep-tissue optogenetics; genetically modified animals; imaging depth; in vivo transparency; model organisms with transparent tissues; optical tissue clearing
Year: 2019 PMID: 31261621 PMCID: PMC6651221 DOI: 10.3390/molecules24132388
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Immunolocalization of αA-crystallin in the caiman retina. (A) αA-crystallin (CRYS, green) is expressed in the inner nuclear layer (INL) surrounding the nuclei of neurons (DAPI nuclear staining, blue). Crystallin is also localized surrounding ganglion cell nuclei (red box) in the ganglion cell layer and in the inner segment area of photoreceptors. (B) αA-crystallin observed from the top of whole-retina tissue. Crystallin is confined to the endfeet of Müller cells in the ganglion cell layer (white arrow). IPL, inner plexiform layer; ILM, inner limiting membrane; GCL, ganglion cell layer; INL, inner nuclear layer; ONL, outer nuclear layer; IS, inner segments of photoreceptors. Scale bar in A, 20 μm and in B, 10 μm.